The two-monthslong sprint among drugmakers to tweak their COVID-19 vaccines could have trampled pandemic response efforts, Céline Gounder, MD, and Elisabeth Rosenthal, MD, Kaiser Health News’ public health editor and editor-in-chief, wrote in a Sept. 9 column.
Read the full post on Becker's Hospital Review - Healthcare News
